SCHEDULE: T. Rowe Price Discloses Stake in Fabrinet

T. Rowe Price Associates, Inc. has reported a 5.4% ownership stake in Fabrinet as of June 30, 2026.

Summary

• T. Rowe Price Associates, Inc. has filed a Schedule 13G, indicating beneficial ownership of 1,941,001 shares of Fabrinet's common stock.
• This represents a 5.4% ownership stake in the company as of June 30, 2026.
• The filing confirms T. Rowe Price Associates, Inc. has sole voting power over 1,870,142 shares and sole dispositive power over 1,941,001 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates increased interest from a major institutional investor, but does not provide company-specific performance data.

Positives

• T. Rowe Price Associates, Inc., a significant institutional investor, has taken a notable stake in Fabrinet, suggesting confidence in the company's prospects.
• The ownership level of 5.4% indicates a substantial investment by T. Rowe Price.

Future Outlook

This filing does not contain forward-looking statements or guidance from Fabrinet. It solely reports the ownership stake of T. Rowe Price Associates, Inc.

Management Comments

• T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

Industry Context

StockSavvy.ai notes that institutional investor filings like this Schedule 13G are common for publicly traded companies and can signal increased interest or conviction from major asset managers in a company's sector.

Stakeholder Impact

• Shareholders may view the increased stake by T. Rowe Price Associates, Inc. as a positive signal of institutional confidence in Fabrinet's future performance.
• The filing does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Fabrinet, T. Rowe Price Associates, Schedule 13G, Ownership Stake, Institutional Investor, Common Stock, Beneficial Ownership